BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29484419)

  • 21. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
    Sengupta S; Jana S; Bhattacharyya A
    Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthocyanidins inhibit epithelial-mesenchymal transition through a TGFβ/Smad2 signaling pathway in glioblastoma cells.
    Ouanouki A; Lamy S; Annabi B
    Mol Carcinog; 2017 Mar; 56(3):1088-1099. PubMed ID: 27649384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
    Kou B; Liu W; Tang X; Kou Q
    Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
    Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
    Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
    Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
    J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling.
    Xia YZ; Shan GF; Yang H; Zha J; Wang L; Chen JM; Zhang XS
    Chem Biol Interact; 2021 Apr; 339():109424. PubMed ID: 33617803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signaling.
    Ono Y; Hayashida T; Konagai A; Okazaki H; Miyao K; Kawachi S; Tanabe M; Shinoda M; Jinno H; Hasegawa H; Kitajima M; Kitagawa Y
    Cancer Sci; 2012 Feb; 103(2):317-24. PubMed ID: 22034928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
    Wang Y; Wang H; Zhou R; Zhong W; Lu S; Ma Z; Chai Y
    Anticancer Drugs; 2017 Jul; 28(6):581-587. PubMed ID: 28379900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
    Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Gieseler F; Ungefroren H
    Mol Cancer; 2015 Nov; 14():199. PubMed ID: 26588899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YXQ-EQ Induces Apoptosis and Inhibits Signaling Pathways Important for Metastasis in Non-Small Cell Lung Carcinoma Cells.
    Yan X; Shen H; Jiang H; Hu D; Wang J; Wu X
    Cell Physiol Biochem; 2018; 49(3):911-919. PubMed ID: 30184531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
    Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
    Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.
    Choi YJ; Baek GY; Park HR; Jo SK; Jung U
    PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
    Li W; Cao L; Chen X; Lei J; Ma Q
    Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEITC inhibits the invasion and migration of colorectal cancer cells by blocking TGF-β-induced EMT.
    Xiao J; Zhou N; Li Y; Xiao Y; Chen W; Ye J; Ma T; Zhang Y
    Biomed Pharmacother; 2020 Oct; 130():110743. PubMed ID: 34321176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.